Joven de 25 años con alteración de la marcha

  1. Carvalho Monteiro, G.
  2. Povedano Margarit, B.
  3. Sánchez Herán, I.
  4. Romero Delgado, F.
  5. Celi Celi, J.M.
  6. Yusta Izquierdo, A.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2019

Títol de l'exemplar: Enfermedades del sistema nervioso (IX)Enfermedades desmielinizantes del sistema nervioso central

Sèrie: 12

Número: 78

Pàgines: 4649-4650

Tipus: Article

DOI: 10.1016/J.MED.2019.05.018 DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Referències bibliogràfiques

  • Chaodong Wang, Zhang KN, Wu XM, Gang Huang, Xie XF, Qu XH. Baló’s disease showing benign clinical course and coexistence with mul-tiple sclerosis-like lesions in Chinese. Mult Scler. 2008;14(3):418-24.
  • Fernández O, Fernández VE, Guerrero M. Esclerosis múltiple. Madrid: McGraw Hill-Interamericana; 2006.
  • Iannuci G, Mascalchi M, Salvi F, Filippi M. Vanishin Baló like lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000;69:399-400.
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-52.
  • Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S,. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131:1759-75.
  • Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis. 2008;14:1157-74.
  • Moore GR, Berry K, Oger JJ, Prout AJ, Graeb DA, Nugent RA. Balo’s concentric sclerosis: Surviving normal myelin in a patient with a relapsing-remitting dinical course. Mult Scler. 2001;7:375-82.
  • Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M. Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. Ann Neurol. 2011;69:292-302.
  • Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess. 2002;6:1.
  • Simon J, Kleinschmidt-DeMasters BK. Variants of multiple sclerosis. Neuroimaging Clin N Am. 2008;18(4):703-16.
  • Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-73.
  • Tintore M, Vidal-Jordana A, Sastre-Garriga J. (2018). Treatment of multiple sclerosis : success from bench to bedside. Nat Rev Neurol. 2019;15(1):53-8.
  • Tourtellotte WW, Booe IM. Multiple sclerosis: the blood brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978;28Suppl:76.
Fuente de los datos: Dialnet